Share this page


M. Amin Khan, Ph.D.

Co-Founder and Senior Advisor, Medicinal Chemistry

Amin brings over 30 years of experience in the pharmaceutical and biotech industry. He was a senior scientist at Elan, Gliatech, and others. Amin discovered and developed multiple novel CNS molecules that entered human clinical trials, including Naurex’s 2nd-generation series of partial agonists of the NMDA receptor. Amin was vice president of chemistry research and development at Naurex and vice president of research and chemistry at Aptynix.

Brian McCormack, MBA

Co-Founder and Advisor

Brian is the founder of McCormack Capital, LLC, managing $420 million, and a prominent investor in Illinois startups, including successes like Echo Global Logistics, Sentry Technology, Tempus, and Groupon, the fastest-growing billion-dollar company in 2008. Brian founded InnerWorkings, now one of the world’s largest printing firms, and co-founded Cresco Labs, a pioneering cannabis company with a market cap exceeding $4 billion. Brian serves on the Board of Rush Health Systems Board, contributing to outstanding patient care, education, and healthcare innovation. Brian led Maryville Academy, the largest orphanage in Illinois, demonstrating his commitment to philanthropy from 2008 to 2018. Since 2023, he has served as a Director at NAMI (National Association for Mental Illness), contributing to mental health advocacy and support.

Ronald Burch, Ph.D., MD

Senior Advisor, Clinical Research and Development

Ron brings over 30 years of extensive experience in the pharmaceutical industry. He has led 20 IND submissions, from which seven products have become marketed, and two are currently in phase 3 clinical trials. Ron is the Chief Medical Officer of Gate Neurosciences. Previously, he was the Director of Pain and inflammation at Nova Pharmaceutical and Head of US Biosciences at Zeneca Pharmaceuticals, where he led the CNS therapeutic area. Ron was also founder and CEO of AlgoRx and co-founder and CMO of Naurex.